A possible association of baseline serum IL-17A concentrations with progression-free survival of metastatic colorectal cancer patients treated with a bevacizumab-based regimen

BACKGROUND: Colorectal cancer is a major public health issue worldwide. Interleukin-17 (IL-17) and Th17 (T-helper cell type 17)-related molecules are involved in tumor development and in resistance to bevacizumab, an anti-vascular endothelial growth factor monoclonal antibody used in association wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Lereclus, Emilie, Tout, Mira, Girault, Alban, Baroukh, Nadine, Caulet, Morgane, Borg, Christophe, Bouché, Olivier, Ternant, David, Paintaud, Gilles, Lecomte, Thierry, Raoul, William
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5368920/
https://www.ncbi.nlm.nih.gov/pubmed/28347290
http://dx.doi.org/10.1186/s12885-017-3210-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5368920/
https://www.ncbi.nlm.nih.gov/pubmed/28347290
http://dx.doi.org/10.1186/s12885-017-3210-z

Ejemplares similares